Authors: PARRA MS CHURRUCA C PAREDES A LACASTA A DEARGUMEDO GL ALVAREZ I ABAD T EGANA L IRIARTE L URRACA JM PIERA JM

Citation: Ms. Parra et al., PHASE-II CLINICAL-TRIAL OF CISPLATIN (CDDP), 5-FLUOROURACIL (5-FU) AND IFOSFAMIDE (IFX) AS TREATMENT FOR ADVANCED LOCOREGIONAL HEAD AND NECK-CARCINOMA (AHNC), Annals of oncology, 9, 1998, pp. 380-380

Authors: GARCIALOPEZ JL SEGUI MA ABAD T GIMENEZARNAU JM MOYANO A NOGUE M DOMINGUEZ S XARLES J

Citation: Jl. Garcialopez et al., PHASE-I DOSE-FINDING TRIAL OF IRINOTECAN (CPT-11) COMBINED WITH IFOSFAMIDE (IFO) IN PATIENTS WITH ADVANCED SOLID TUMORS, Annals of oncology, 9, 1998, pp. 649-649

Authors: LOPEZ B CUEVA JF DOMINGUEZ S RUIZ A LOPEZBREA M LOPEZMARTIN JA JUAN O ABAD T

Citation: B. Lopez et al., DOUBLE BIOCHEMICAL MODULATION OF CISPLATIN, LEUCOVORIN AND 5-FLUOROURACIL IN ADVANCED GASTRIC-CANCER, European journal of cancer, 33, 1997, pp. 1261-1261

Authors: KRAKOWSKI M CZOBOR P CARPENTER MD LIBIGER J KUNZ M PAPEZOVA H PARKER BB SCHMADER L ABAD T

Citation: M. Krakowski et al., COMMUNITY VIOLENCE AND INPATIENT ASSAULTS - NEUROBIOLOGICAL DEFICITS, The Journal of neuropsychiatry and clinical neurosciences, 9(4), 1997, pp. 549-555